These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Soluble thrombomodulin as predictor of incident coronary heart disease. Cella G; Randi ML Lancet; 1999 Jul; 354(9176):425. PubMed ID: 10437896 [No Abstract] [Full Text] [Related]
3. Soluble thrombomodulin as predictor of incident coronary heart disease. Salomaa V; Wu KK Lancet; 1999 Nov; 354(9190):1646-7. PubMed ID: 10560702 [No Abstract] [Full Text] [Related]
4. Thrombomodulin levels during normal pregnancy, at delivery and in the postpartum: comparison with tissue-type plasminogen activator and plasminogen activator inhibitor-1. de Moerloose P; Mermillod N; Amiral J; Reber G Thromb Haemost; 1998 Mar; 79(3):554-6. PubMed ID: 9531039 [TBL] [Abstract][Full Text] [Related]
5. Predictive value of fibrinolytic factors in coronary heart disease. Wiman B Scand J Clin Lab Invest Suppl; 1999; 230():23-31. PubMed ID: 10389198 [TBL] [Abstract][Full Text] [Related]
10. Regulators of fibrynolysis in plasma of kidney transplant recipients. Perkowska A; Elhasade A; Gaciong Z; Durlik M; Placha G; Galazka Z; Lao M Transplant Proc; 2002 Mar; 34(2):585-8. PubMed ID: 12009632 [No Abstract] [Full Text] [Related]
11. Activated protein C ratio, plasma tissue factor activity and activated factor VII in Chinese patients with coronary heart disease. He WJ; Hu Y; Zhang XP; Hong M; Guo T; Wei WN; Song SJ Eur J Med Res; 2008 Feb; 13(2):47-51. PubMed ID: 18424361 [TBL] [Abstract][Full Text] [Related]
13. Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosis. Herrick AL; Illingworth K; Blann A; Hay CR; Hollis S; Jayson MI Ann Rheum Dis; 1996 Feb; 55(2):122-7. PubMed ID: 8712862 [TBL] [Abstract][Full Text] [Related]
14. Dengue virus regulates the expression of hemostasis-related molecules in human vein endothelial cells. Jiang Z; Tang X; Xiao R; Jiang L; Chen X J Infect; 2007 Aug; 55(2):e23-8. PubMed ID: 17573116 [TBL] [Abstract][Full Text] [Related]
15. Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease. Lahlou-Laforet K; Alhenc-Gelas M; Pornin M; Bydlowski S; Seigneur E; Benetos A; Kierzin JM; Scarabin PY; Ducimetiere P; Aiach M; Guize L; Consoli SM Am J Cardiol; 2006 May; 97(9):1287-91. PubMed ID: 16635597 [TBL] [Abstract][Full Text] [Related]
16. High concentration of thrombomodulin in plasma is associated with hemorrhage: a prospective study in patients receiving long-term anticoagulant treatment. Jansson JH; Boman K; Brännström M; Nilsson TK Circulation; 1997 Nov; 96(9):2938-43. PubMed ID: 9386160 [TBL] [Abstract][Full Text] [Related]
17. Changes in plasminogen activator inhibitor 1 and tissue-type plasminogen activator during exercise in patients with coronary artery disease. Rydzewski A; Sakata K; Kobayashi A; Yamazaki N; Urano T; Takada Y; Takada A Haemostasis; 1990; 20(5):305-12. PubMed ID: 2127039 [TBL] [Abstract][Full Text] [Related]
18. [Dehydroepiandrosterone therapy in men with angiographically verified coronary heart disease: the effects on plasminogen activator inhibitor-1 (PAI-1), tissue plasminogen activator (tPA) and fibrinogen plasma concentrations]. Rabijewski M; Zgliczyński W Endokrynol Pol; 2007; 58(3):213-9. PubMed ID: 17940987 [TBL] [Abstract][Full Text] [Related]
19. [A study on the reserve capacity of endothelial tissue plasminogen activator in patients with acute coronary syndrome]. Yan J; Huang Z; Liu R; Li L; Han C; Yang J Zhonghua Nei Ke Za Zhi; 1999 Dec; 38(12):817-20. PubMed ID: 11798724 [TBL] [Abstract][Full Text] [Related]